Headline News
Equillium Announces Interim Safety Data And Reduction In Proteinuria For Lupus Patients Treated With Itolizumab In The EQUALISE Study Presented At The ACR Annual Meeting
by | Nov 2, 2021 | Uncategorized | 0 comments

by | Nov 2, 2021 | Uncategorized | 0 comments
Headline News
Recent Comments